Secular Trends in the Incidence of Female Breast Cancer in the United States, 1973-1998

Breast Journal

Volumn 10, Issue 2, 2004, Pages 129-135

  Nasseri, Kiumarss ^a,b  

^a Cancer Center Santa Barbara   (United States)

^b Tri Counties Cancer Surveillance Program   (United States)

Author keywords

Breast cancer; Early detection; Joinpoint; Secular trend; SEER

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; EARLY DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; REGRESSION ANALYSIS; STATISTICAL MODEL; TUMOR LOCALIZATION; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; CAUSALITY; EARLY DIAGNOSIS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; SEER PROGRAM; UNITED STATES;

EID: 1642305689     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2004.21276.x     Document Type: Article

References (34)

1. Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1973-1998. Bethesda, MD: National Cancer Institute, 2001.
2. Miller AB, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection. An update. CA Cancer J Clin 1993;43:27-41.
3. Zheng T, Holford TR, Chen Y, Jones BA, Flannery J, Boyle P. Time trend of female breast carcinoma in situ by race and histology in Connecticut, USA. Eur J Cancer 1997;33:96-100.
4. White E, Lee CL, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 1990;82:1546-52.
5. Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 1992;136:1423-36.
6. King SE, Schottenfeld D. The "epidemic" of breast cancer in the U.S. - determining the factors. Oncology 1996;10:453-62.
7. Howard J. Using mammography for cancer control: an unrealized potential CA Cancer J Clin 1987;37:33-48.
8. Self-reported use of mammography among women aged 40 and over-United States, 1988-1995. MMWR Morb Mortal Wkly Rep 1997;46:937-40.
9. McCann J, Stockton D, Day N. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen 1998;5:42-48.
10. Ernster VL, Barclay J. Increase in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr 1997;22:151-56.
11. Richardson LC, Schulman J, Sever LE, Lee NC, Coate RJ. Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995. Breast Cancer Res Treat 2001;69:133-42.
12. SEER information. Available at http://seer.cancer.gov/about/.
13. Shambaugh EM, Weiss MA, eds. Summary Staging Guide: Cancer Surveillance, Epidemiology, and End Results Reporting. Publication 98-2313. Bethesda, MD: National Institutes of Health, 1977; reprint 1998.
14. SEER Extent of Disease 1988: Codes and Coding Instructions, 3rd ed. Publication 98-1999. Bethesda, MD: National Institutes of Health, 1998.
15. Sickles EA, Weber WN, Galvin HB, Ominsky SH, Sollitto RA. Baseline mammography: one vs two views per breast. AJR Am J Roentgenol 1986;147:1149-53.
16. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. Report of the U.S. Preventive Services Task Force, 2nd ed. Baltimore: Williams & Wilkins, 1996.
17. Eastman P. NCI adopts new mammography screening guidelines for women. J Natl Cancer Inst 1997;89:538-39.
18. Leitch AM, Dodd GD, Costanza M, et al. American Cancer Society guidelines for early detection of breast cancer: update 1997. CA Cancer J Clin 1997;47:150-53.
19. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on gamma distribution. Stat Med 1997;16:791-801.
20. Census Bureau population estimates. Available at http://www.census.gov/population/www/estimates/countypop.html.
21. Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for Joinpoint regression with application to cancer rates. Stat Med 2000;19:335-51.
22. Edwards BK, Howe HL, Ries LAG, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on the US cancer burden. Cancer 2002;94:2766-92.
23. McCarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc 2000;48:1226-33.
24. Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg 1999;230:692-96.
25. Vacek PM, Geller BM, Weaver DL, Foster RS Jr. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999. Cancer 2002;94:2160-68.
26. Cody HS 3rd. The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993: equal value for patients younger and older than age 50 years. Cancer 1995;76:579-84.
27. Shapiro S, Strax P, Vene L, Roser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55.
28. American Cancer Society. National Task Force on Breast Cancer Control. Mammography 1982: a statement of the American Cancer Society. CA Cancer J Clin 1982;32:226-30.
29. Morrison AS. Screening. In: Rothman KJ, Greenland S, eds. Modern Epidemiology, 2nd ed. Philadelphia: Lippincott-Raven, 1998:499-528.
30. Fox HS, Moskowitz M, Saenger EL, Kerelakes JG, Milbrath J, Goodman MW. Benefit/risk analysis of aggressive mammographic screening. Radiology 1978;128:359-65.
31. National Institute of Health Consensus Development Panel. National Institute of Health Consensus Development Conference statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J Natl Cancer Inst Monogr 1997;22:vii-xviii.
32. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer. Arch Surg 1999;134:764-67.
33. Mincey BA, Bammer T, Atkinson EJ, Perez EA. Role of axillary node dissection in patients with T1a and T1b breast cancer. Arch Surg 2001;136:779-82.
34. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey B. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-45.